Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Oleoylethanolamide

Fatty-acidFatty acid amide

Useful mainly for adults wanting appetite/weight support, accepting preliminary evidence.

Quick decision guide

May help most

adults wanting appetite/weight support, accepting preliminary evidence

Common dosing range

Commonly ~100–300 mg/day per product labels

When to expect effects

Weeks

Watch out for

Human efficacy is unproven; not a substitute for diet

What is it

Oleoylethanolamide (OEA) is a naturally occurring lipid mediator produced in the gut from oleic acid that signals satiety, mainly by activating the PPAR-alpha receptor. It is sold as a supplement for appetite control and weight management. Human evidence is early and limited, with most support coming from animal and mechanistic studies.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You want to trial an appetite-modulating supplement alongside diet
You will track intake and weight and stop if there is no effect

Probably skip if…

You expect substantial weight loss on its own
You want proven, replicated human results
You are pregnant or have an eating disorder

Evidence at a glance

appetite control and weight management

Limited Evidence
Effect
Small/uncertain
Best fit
adults using it as an adjunct to a reduced-calorie diet
Time
Weeks

Evidence for 1 use

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

appetite control and weight management

Supplement benefit
Limited Evidence

OEA is a well-characterized satiety signal that reduces food intake and body weight in animal models via PPAR-alpha. A small number of human studies suggest modest effects on appetite or weight when combined with diet, but trials are few, small and sometimes use related formulations. Clinical benefit in people remains preliminary.

Effect size
Small/uncertain
Time to effect
Weeks
Best fit
adults using it as an adjunct to a reduced-calorie diet
Less likely
people expecting weight loss without dietary change

Bottom line: A mechanistically sound satiety mediator with only preliminary human weight data.

Evidence is mixed

Strong animal/mechanistic data are not yet matched by robust, replicated human trials.

SourceLaleh et al., 2018 — PubMed· conflicting
SourceLaleh et al., 2018 — PubMed

How to take it

1. Typical dose
~100–300 mg/day per label
2. Timing
Before meals (aligns with its satiety role)
3. With food
Shortly before food
4. How long to try
Trial 8–12 weeks and reassess

What to track

Appetite and portion sizes
Body weight
GI tolerance

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Mild GI upsetNausea

Who should avoid it

  • Pregnant or breastfeeding people
  • People with eating disorders
  • Children

Pregnancy & breastfeeding

Avoid; safety has not been established.

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Stated mg of oleoylethanolamide per serving
Purity and third-party testing
No undisclosed stimulant blends

Be skeptical of…

Effortless fat loss
Clinically proven weight-loss drug
Appetite cure

References by claim

appetite control and weight management

Laleh et al., 2018 — PubMed (2018) link

Track Oleoylethanolamide with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.